Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis: association with clinical and MRI activity. (Q48602270)

13 February 2018

title

Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis: association with clinical and MRI activity. (English)

1 reference

13 February 2018

relapsing-remitting multiple sclerosis

main subject

0 references

multiple sclerosis

0 references

author name string

Niels Hellings

1

1 reference

13 February 2018

Geert Gelin

2

1 reference

13 February 2018

Robert Medaer

3

1 reference

13 February 2018

Liesbeth Bruckers

4

1 reference

13 February 2018

Yvan Palmers

5

1 reference

13 February 2018

Jef Raus

6

1 reference

13 February 2018

Piet Stinissen

7

1 reference

13 February 2018

publication date

1 May 2002

1 reference

13 February 2018

Journal of Neuroimmunology

published in

1 reference

13 February 2018

volume

126

1 reference

13 February 2018

issue

1-2

1 reference

13 February 2018

page(s)

143-160

1 reference

13 February 2018

Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

T cell necessity in the pathogenesis of experimental autoimmune encephalomyelitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Expression, purification, and encephalitogenicity of recombinant human myelin oligodendrocyte glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

T cell receptor V beta gene usage in the recognition of myelin basic protein by cerebrospinal fluid- and blood-derived T cells from patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

CD4 subsets (CD45RA/RO) exhibit differences in proliferative responses, IL-2 and gamma-interferon production during intravenous methylprednisolone treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Nervous tissue as an immune compartment: the dialect of the immune response in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Circulating adhesion molecules and inflammatory mediators in demyelination: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Insights into the immunopathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Tumor necrosis factor identified in multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Soluble and cell surface ICAM-1 as markers for disease activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Longitudinal study of myelin basic protein-specific T-cell receptors during the course of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Clinical and radiologic correlates of a novel T lymphocyte gamma-interferon-activated Ca2+ influx in patients with relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Review: cytokines and the pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Multiple sclerosis: in relapsing patients, immune functions vary with disease activity as assessed by MRI

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

B cells capable of spontaneous IgG secretion in cerebrospinal fluid from patients with multiple sclerosis: dependency on local IL-6 production

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

A cell culture model for T lymphocyte clonal anergy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Autoimmune T cell repertoire in optic neuritis and multiple sclerosis: T cells recognising multiple myelin proteins are accumulated in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Biological markers in body fluids for activity and progression in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Diversity and plasticity of self recognition during the development of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900052-8

7 January 2021

10.1016/S0165-5728(02)00052-8

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

12020966

1 reference

13 February 2018